To identify the upstream signalling that governs PD-L1 stabilization, we subjected various cancer cell lines to several growth factors that are known to inhibit GSK3β activity, such as epidermal growth factor (EGF), insulin-like growth factor-1, hepatocyte growth factor, fibroblast growth factor and transforming growth factor (TGF)-β. Here, EGF is linked to cancer.